Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

Figure 1

Conditional expectation of the serum level of miR-155, miR-19a, miR-181b, and miR-24 through the therapy in case of a common BC patient (high-risk patients in upper A panel, low-risk patients in bottom B panel) and its comparison to the control. The predicted development (mainly decrease) of the serum level for each oncomiR is calculated using the multivariate longitudinal data analysis introduced within Methods and Results sections and also provided in the Table 1.

Back to article page